Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002102
Filing Date
2008-02-29
Accepted
2008-02-29 17:03:09
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183052z10-k.htm 10-K 964254
2 EXHIBIT 10.25 a2183052zex-10_25.htm EX-10.25 49322
3 EXHIBIT 10.34 a2183052zex-10_34.htm EX-10.34 96108
4 EXHIBIT 10.36 a2183052zex-10_36.htm EX-10.36 96746
5 EXHIBIT 10.37 a2183052zex-10_37.htm EX-10.37 526937
6 EXHIBIT 14.1 a2183052zex-14_1.htm EX-14.1 33640
7 EXHIBIT 23.1 a2183052zex-23_1.htm EX-23.1 2537
8 EXHIBIT 31.1 a2183052zex-31_1.htm EX-31.1 6897
9 EXHIBIT 31.2 a2183052zex-31_2.htm EX-31.2 6908
10 EXHIBIT 32.1 a2183052zex-32_1.htm EX-32.1 3032
11 EXHIBIT 32.2 a2183052zex-32_2.htm EX-32.2 3020
12 G443511.JPG g443511.jpg GRAPHIC 21393
  Complete submission text file 0001047469-08-002102.txt   1820396
Mailing Address 24 EMILY ST CAMBRIDGE MA 02139
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21379 | Film No.: 08656746
SIC: 2834 Pharmaceutical Preparations